On August 14, 2009, the FDA approved the Asenapine maleate for emergency treatment of adult schizophrenia, mania or mixed attacks with type I bipolar disorder. In addition an alter native process for the conversion of the mixture of cis- and trans- lactam into the desired trans-isomer has been developed with good yield.